VRNA Verona Pharma plc ADRs

Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:VRP.

$4.36  +0.18 (4.19%)
As of 05/25/2022 15:53:42 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  04/27/2017
Outstanding shares:  60,368,049
Average volume:  159,990
Market cap:   $249,923,723
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -20.66
PB ratio:   2.00
PS ratio:   3.12
Return on equity:   -46.80%
Net income %:   -73.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy